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ABSTRACT.  
We used a microfluidic platform to address the problems of obtaining diffraction quality 
crystals and crystal handling during transfer to the X-ray diffractometer. We optimize 
crystallization conditions of a pharmaceutical protein and collect X-ray data both in situ and ex 
situ. 
 
 
1. Introduction 
Structural biologists need to solve three-dimensional structures of biological macromolecules 
via X-ray crystallography. Two decisive and rate-limiting steps are obtaining diffraction-quality 
crystals and handling crystals during transfer to the diffractometer.  
Obtaining diffraction-quality crystals is complex and influenced by many parameters (pH, 
temperature, types of buffer, salts and crystallization agents). Problems in producing suitable 
crystals can be tackled in two steps: first, screening for favourable crystallization conditions in 
the phase diagram and second, optimizing crystal growth by developing a specific kinetic path 
in the phase diagram. Screening is an expensive task, both in terms of time and raw materials. 
Moreover, when only small quantities of sample materials are available, a suitable experimental 
tool is essential. Microfluidic techniques, i.e. the control and manipulation of flows at sub-
millimetre scale using miniaturized devices called Lab On Chip (LOC)(van der Woerd et al., 
2003) are appropriate for automating, miniaturizing and high-throughput crystallization 
approaches involving multiple operations such as mixing, analysis, separation(Leng J. & 
Salmon J.B., 2009). LOCs are applied in both fast screening and optimization stages of protein 
crystallization studies, via the integration of traditional protocols of protein 
crystallization(Candoni N. et al., 2012). Furthermore, the microfluidics approach suits the 
stochastic nature of nucleation(Hammadi et al., 2015) because it allows multiple independent 
experiments.  
Manual handling of the sample crystals can mechanically and environmentally stress them. The 
stress induced during this delicate step may affect crystal quality and decrease its diffractive 
power. To minimize manual handling, an alternative is in situ X-ray data collection. One 
method involves using X-ray-transparent microfluidic devices (Hansen et al., 2006, Dhouib et 
al., 2009, Stojanoff et al., 2011, Guha et al., 2012, Pinker et al., 2013, Khvostichenko et al., 
2 
 
2014, Horstman et al., 2015, Heymann et al., 2015, Maeki et al., 2015). Another solution 
following Yadav’s pioneering work (Yadav et al., 2005), is to collect X-ray data directly in 
micro capillary (Li et al., 2006, Maeki et al., 2012). For ex situ data collection, Gerdts (Gerdts 
et al., 2010) and Stojanoff (Stojanoff et al., 2011) harvested a protein crystal from a 
microfluidic chanel using a cryo-loop and Li(Li et al., 2006) made crystals flow out of a 
capillary, then looped and flash-froze them. 
 We present an application that addresses these two problems using a microfluidic 
platform developed in our group.(Zhang et al., 2017) We optimize crystallization conditions of  
human Quinose Reductase 2 (QR2 EC 1.10.5.1)(Nosjean et al., 2000), and collect X-ray data 
both in situ and ex situ to characterize the crystals obtained. 
 
 2. Optimization and crystallization results using the microfluidic platform 
The microfluidic platform developed in our group offers four modular functions(Zhang et al., 
2017): droplet formation, on-line UV characterization, incubation and observation (figure 1). 
We adapt the platform to generate droplets of 2nL in long Teflon tubing (150µm ID from IDEX 
Health and Science), without using surfactant.(Zhang et al., 2015) Droplets are generated by 
crossing a continuous phase (FC70 fluorinated oil from Hampton research) with dispersed 
phases (containing the protein and the crystallization agent(s)) in a microfluidic junction (Te, 
cross or 7-entry junction from IDEX Health and Science). A programmable syringe pump 
(neMESYS, cetoni GmbH) controls the flow-rates of the different fluids. We couple an on-line 
UV detector (USB2000+, Ocean optics) to the Teflon tubing after the droplet formation zone 
((3) in figure 1). We use on-line analysis of the droplets by UV spectrometry to characterize the 
chemical composition gradient generated among droplets of identical sizes.(Zhang et al., 2017)  
 
 
Figure 1. Pictures of the home-made microfluidic platform: (1) syringe pump, (2) 7-entry junction, (3) 
on-line UV module (4) tubing-holder for thermostatting and observation with XYZ-motorized camera.  
 
Experimental conditions are based both on solubilities obtained by equilibrating crystal-
solution suspensions over time (figure 1, Supplementary Information) and crystallization 
conditions used for structural determination.(Foster et al., 1999) Subsequent gradient 
optimization, using experimental conditions presented in figure 2, provides optimal conditions 
3 
 
leading to high quality crystals. At least 60 droplets of 2nL per experimental conditions were 
generated and observed (figure 2). Crystals in droplets from experiment (b) (figure 2) were used 
for X-ray diffraction (XRD).  
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Figure 2. Solubility of QR2 versus (NH4)2SO4 at pH=8 (20mM Tris-HCl and 150mM NaCl), and the 
different experimental conditions tested in the fine-gradient experiment. The dashed line is a guide for 
the eye to separate the crystallization and precipitation zones.  
Photos of 5 representative droplets obtained in 2nL droplets in Teflon capillary (150µm ID) after 24h. 
(a) 11 mg/mL QR2, 0.9M (NH4)2 SO4, (b) 5.5 mg/mL QR2, 1.35M (NH4)2 SO4, (c) 11 mg/mL QR2, 
1.2M (NH4)2 SO4, (d) 3.7 mg/mL QR2, 1.8M (NH4)2 SO4, (e) 5.5 mg/mL QR2, 1.8M (NH4)2 SO4, at 
20°C.  
 
3. XRD characterization  
Although direct X-ray data collection from the microfluidic devices is used to minimize manual 
handling, Teflon-related background noise is significant on diffraction patterns. This may 
reduce the quality of the diffraction data (Yadav et al., 2005) and strongly reduce the observed 
diffraction limits of the crystals. Hence, we tested two approaches: (1) transferring droplets 
containing the crystals of interest from Teflon to silica tubing for in situ XRD without freezing; 
and (2) extracting the crystals of interest from the tubing, depositing them on a MicroMeshTM, 
a polyimide grid transparent to X-rays, for ex situ XRD thereby avoiding mechanical shocks.  
3.1. In situ XRD. We transferred the droplets from experiment (b), performed in Teflon 
tubing, to silica tubing (fused silica tubing with a polyimide coating -150µm ID, 360µm OD, 
from  IDEX health and science) using a linear junction (IDEX health and science). The internal 
silica tubing wall was coated with a commercial hydrophobic surface-coating agent (Aquapel®, 
PPG industry)(Mazutis et al., 2009) to ensure droplet stability. The silica tubing containing the 
droplets was directly mounted on a magnetic base extracted from standard SPINE sample loops, 
ready for transfer to the X-ray setup (figure 3). For the proof of concept, a single crystal was 
analysed by XRD at room temperature on the beam line PROXIMA 1 (Synchrotron SOLEIL). 
Diffraction was observed to a resolution of 2.7 Å (figure 2, Supplementary Information). 
However, the strong X-ray damage to the crystal from these room-temperature measurements 
most likely explains why a complete data set was not obtained from one single crystal. 
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Microfluidics, however, can produce hundreds to thousands of droplets with identical 
composition. Thus, serial-crystallography at room temperature would yield a complete set of 
data for structural resolution with limited noticeable effects from radiation damage. This 
approach was used recently by Heymann(Heymann et al., 2015) with a chip made of PDMS 
and COC (cyclic olefin polymer) or Kapton. 
 
 
Figure 3. Photos of the silica tubing mounted on a magnetic base. 
 
3.2. Ex situ XRD. Here, crystals were harvested from the Teflon tubing containing 
droplets. A droplet was deposited on a MicromeshTM (MiTeGen) using a high-precision micro-
injector for flow control (Elveflow). The micro-injector and the MicroMeshTM are fixed to 
home-made micromanipulators for precise displacement in X, Y and Z(Grossier R. et al., 2011) 
(figure 3, Supplementary Information). Crystals were placed singly on the MicroMeshTM 
(figure 4 and figure 4 and video 1, Supplementary Information) which was immediately 
extracted from the oil bath (FC70) and immersed in liquid nitrogen to cryogenize the crystals. 
Here, FC70 oil acted as a cryoprotectant, but crystals can be immersed in a drop of glycerol for 
cryoprotection. Then, XRD was carried out. By extracting the crystals without direct handling 
or mechanical stress and preparing the sample for diffraction studies under cryogenic 
conditions, we were able to collect a full data set at a resolution of 2.3Å (with or without 
glycerol). By determining structure from one single crystal, we identified electron density for 
the Flavin Adenine Dinucleotide (FAD) cofactor in the active site of QR2 (figure 5). Further 
studies should explore screening of QR2 co-crystallization with ligands for structure-based drug 
design. These first results confirm that the microfluidic approach yields crystallographic data 
of sufficient quality to allow us to judge whether or not the ligands bind to the active site.  
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Figure 4. Photo of a crystal in a droplet deposited on the MicromeshTM. 
 
 
Figure 5. Electronic density map of the active site of QR2, with the FAD cofactor. 
 
4. Conclusions 
We present an application of a microfluidic platform developed in our group to the optimization 
of crystallization conditions of the pharmaceutical protein QR2. The resulting crystals were 
characterized by both in situ and ex situ X-ray diffraction. 
 
Acknowledgments 
We thank the Institut de Recherche Servier for financial support. We thank T. Bactivelane 
(CINaM), M. Lagaize (CINaM) and M. Audiffren (ANACRISMAT) for technical assistance. 
We thank G. Sulzenbacher, S. Spinelli and P. Cantau (AFMB) for the transport of the crystals 
and their support about crystallography. Experiments at Synchrotron SOLEIL were performed 
under the in house proposal number 99150097. Results incorporated in this note received 
funding from the European Union's Horizon 2020 research and innovation programme under 
grant agreement No 708130. 
  
6 
 
References 
Candoni N., Grossier R., Hammadi Z., Morin R. & Veesler S. (2012). Protein & Peptide Letters 19, 714-
724. 
Dhouib, K., Khan Malek, C., Pfleging, W., Gauthier-Manuel, B., Duffait, R., Thuillier, G., Ferrigno, R., 
Jacquamet, L., Ohana, J., Ferrer, J.-L., Theobald-Dietrich, A., Giege, R., Lorber, B. & Sauter, C. 
(2009). Lab on a Chip 9, 1412-1421. 
Foster, C. E., Bianchet, M. A., Talalay, P., Zhao, Q. & Amzel, L. M. (1999). Biochemistry 38, 9881-9886. 
Gerdts, C. J., Stahl, G. L., Napuli, A., Staker, B., Abendroth, J., Edwards, T. E., Myler, P., Van Voorhis, 
W., Nollert, P. & Stewart, L. J. (2010). Journal of Applied Crystallography 43, 1078-1083. 
Grossier R., Hammadi Z., Morin  R., Magnaldo A. & veesler S (2011). Applied Physics Letters 98, 
091916-091913. 
Guha, S., Perry, S. L., Pawate, A. S. & Kenis, P. J. A. (2012). Sensors and Actuators B: Chemical 174, 1-
9. 
Hammadi, Z., Grossier, R., Zhang, S., Ikni, A., Candoni, N., Morin, R. & Veesler, S. (2015). Faraday 
Discussions 179, 489-501. 
Hansen, C. L., Classen, S., Berger, J. M. & Quake, S. R. (2006). Journal of the American Chemical 
Society 128, 3142-3143. 
Heymann, M., Opathalage, A., Wierman, J. L., Akella, S., Szebenyi, D. M. E., Gruner, S. M. & Fraden, S. 
(2015). IUCrJ 2, 601. 
Horstman, E. M., Goyal, S., Pawate, A., Lee, G., Zhang, G. G. Z., Gong, Y. & Kenis, P. J. A. (2015). 
Crystal Growth & Design. 
Khvostichenko, D. S., Schieferstein, J. M., Pawate, A. S., Laible, P. D. & Kenis, P. J. A. (2014). Crystal 
Growth & Design. 
Leng J. & Salmon J.B. (2009). Lab on a Chip 9, 24-34. 
Li, L., Mustafi, D., Fu, Q., Tereshko, V., Chen, D. L., Tice, J. D. & Ismagilov, R. F. (2006). Proceedings of 
the National Academy of Sciences 103, 19243-19248. 
Maeki, M., Pawate, A. S., Yamashita, K., Kawamoto, M., Tokeshi, M., Kenis, P. J. A. & Miyazaki, M. 
(2015). Analytical Chemistry 87, 4194-4200. 
Maeki, M., Yoshizuka, S., Yamaguchi, H., Kawamoto, M., Yamashita, K., Nakamura, H., Miyazaki, M. & 
Maeda, H. (2012). Analytical Sciences 28, 65-65. 
Mazutis, L., Araghi, A. F., Miller, O. J., Baret, J.-C., Frenz, L., Janoshazi, A., Taly, V., Miller, B. J., 
Hutchison, J. B., Link, D., Griffiths, A. D. & Ryckelynck, M. (2009). Analytical Chemistry 81, 
4813-4821. 
Nosjean, O., Ferro, M., Cogé, F., Beauverger, P., Henlin, J.-M., Lefoulon, F., Fauchère, J.-L., 
Delagrange, P., Canet, E. & Boutin, J. A. (2000). Journal of Biological Chemistry 275, 31311-
31317. 
Pinker, F., Brun, M., Morin, P., Deman, A.-L., Chateaux, J.-F., Oliéric, V., Stirnimann, C., Lorber, B., 
Terrier, N., Ferrigno, R. & Sauter, C. (2013). Crystal Growth & Design 13, 3333-3340. 
Stojanoff, V., Jakoncic, J., Oren, D. A., Nagarajan, V., Navarro Poulsen, J.-C., Adams-Cioaba, M. A., 
Bergfors, T. & Sommer, M. O. A. (2011). Acta Crystallographica Section F 67, 971-975. 
van der Woerd, M., Ferree, D. & Pusey, M. (2003). Journal of Structural Biology 142, 180-187. 
Yadav, M. K., Gerdts, C. J., Sanishvili, R., Smith, W. W., Roach, L. S., Ismagilov, R. F., Kuhn, P. & 
Stevens, R. C. (2005). Journal of Applied Crystallography 38, 900-905. 
Zhang, S., Ferté, N., Candoni, N. & Veesler, S. (2015). Organic Process Research & Development 19, 
1837-1841. 
Zhang, S., Gerard, C. J. J., Ikni, A., Ferry, G., Vuillard, L. M., Boutin, J. A., Ferte, N., Grossier, R., 
Candoni, N. & Veesler, S. (2017). Journal of Crystal Growth. 
 
